On the basis of our recent study on PD-L1 and the present study, we have further identified SLC7A11 as another important therapeutic target in macrophages for prevention of persistent infection in a setting of subacute S. aureus osteomyelitis. Here, SLC7A11 is linked to osteomyelitis.